Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
6.95
0.00 (0.00%)
At close: Sep 4, 2026, 4:00 PM EDT
7.06
+0.11 (1.54%)
Pre-market: Sep 8, 2026, 8:01 AM EDT

Ginkgo Bioworks Holdings Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-290.8-312.76-547.03-892.87-2,105-1,830
Depreciation & Amortization
35.4340.2945.0254.8142.5529.08
Other Amortization
18.618.71815.7--
Loss (Gain) From Sale of Assets
--7.8643.34-28.8-
Asset Writedown & Restructuring Costs
--78.27130.591.16-
Loss (Gain) From Sale of Investments
8.213.0228.8354.8353.3411.54
Loss (Gain) on Equity Investments
4.67--2.6443.7677.28
Stock-Based Compensation
68.8181.55112.34229.881,9311,606
Other Operating Activities
17.1632.2426.7935.75-152.92-86.16
Change in Accounts Receivable
-0.2-1.47-4.7350.0755.02-114.09
Change in Accounts Payable
-7.31-2.994.77-1.18-10.84-2.25
Change in Unearned Revenue
-14.03-32.39-68.65-35.92-36.42-10.5
Change in Other Net Operating Assets
-18.89-7.23-21.0716.87-44.7765.3
Operating Cash Flow
-170.24-171.06-319.59-295.5-252.2-253.82
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-4.56-7.67-62.54-40.8-52.27-56.52
Sale of Property, Plant & Equipment
0.570.570.654.43--
Cash Acquisitions
---5.4-74.73-12.04
Divestitures
----42.98-55.72-
Investment in Securities
60.65-233.254.52--3.69-5
Other Investing Activities
-0.160.050.54-1.34-30.440.3
Investing Cash Flow
56.5-240.29-62.24-80.69-67.39-73.26

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
--0.35-0.9-1.3-1.24-1.12
Net Debt Issued (Repaid)
-0.07-0.35-0.9-1.3-1.24-1.12
Issuance of Common Stock
36.5219.470.080.0999.542,485
Repurchase of Common Stock
----0.02-0.98-901.71
Other Financing Activities
-1.9-1.34-0.93-1.99-1.99-48.19
Financing Cash Flow
34.5517.78-1.74-3.2295.341,534

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.150.2-0.28-0.590.91-0.02
Net Cash Flow
-79.34-393.37-383.84-380-223.351,207

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-174.8-178.72-382.13-336.3-304.47-310.34
Free Cash Flow Growth
------
Free Cash Flow Margin
-132.00%-105.04%-168.31%-133.74%-63.74%-98.89%
Free Cash Flow Per Share
-2.98-3.22-7.36-6.92-7.25-9.13
Levered Free Cash Flow
-72.4-72.88-238.01-119.75596.72444.82
Unlevered Free Cash Flow
-72.4-72.88-237.96-119.69596.78446.31

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
000.030.080.092.37
Cash Income Tax Paid
0.190.190.890.67-0.06
Change in Working Capital
-40.43-44.09-89.6729.84-37.01-61.54
SEC Filings: 10-K · 10-Q